Evidence map›Paper›PMID 41917360›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

A Vortex-Shear-Based Assay for Cleavage of Multimeric VWF by ADAMTS13.

Xiaxin Dong, Wenjing Cao, X Long Zheng

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaxin DongDepartment of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.
Wenjing CaoDepartment of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.
X Long ZhengDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. xzheng2@kumc.edu.

Funding

Pathogenesis of thrombotic microangiopathiesR01HL164016 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI X. Long Zheng · 2023 to 2026
$2.1M
Mechanism underlying cofactor-dependent proteolysis of von Willebrand FactorR01HL157975 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ZHANG, XIAOHUI FRANK, ZHENG, X. LONG · 2022 to 2025
$1.8M
NHLBI NIH HHS R01 HL157975NHLBI NIH HHS R01 HL164016
6 · The paper itself

Abstract

Proteolytic cleavage of von Willebrand factor (VWF) by ADAMTS13 is a critical regulatory mechanism that maintains hemostatic balance, which directly influences VWF platelet adhesive function. In circulation, VWF adopts a globular conformation that is resistant to proteolysis by ADAMTS13. Exposure to high shear stress, as seen in the small arteries and microvasculature, induces VWF unfolding, which exposes the cleavage site within the A2 domain and allows ADAMTS13 to cleave VWF at the Tyr1605-Met1606 bond. Conventional assays for cleavage of multimeric VWF by ADAMTS13 rely on unfolding of VWF by denaturants such as urea or guanidine-HCl. Our laboratory first developed the vortex-shear-based assay that applies a mechanical shear in a small test tube to induce VWF unfolding for ADAMTS13 cleavage. The assay allows us to assess the proteolytic activity of ADAMTS13 and its cofactor-dependent regulatory function under physiologically relevant conditions. This chapter provides a detailed protocol for performing the vortex-based assay for research purpose.

Indexed as

ADAMTS13 Proteinvon Willebrand FactorHumansProtein MultimerizationProteolysisStress, MechanicalADAMTS13 ProteinADAMTS13 protein, humanvon Willebrand FactorADAMTS13CleavageMechanical shearMultimeric VWFTurbulent flowVortex assay

Identifiers

PMID41917360
PMCPMC13334724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.